Skip to content

Medical-device intelligence

QFT: Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder

FDA product code QFT: Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QFT
FDA device name
Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder
Device class
2
Regulation number
882.5803
Medical specialty
Obstetrics/Gynecology
Review panel
NE

FDA definition

A digital therapy device for Attention Deficit Hyperactivity Disorder (ADHD) is a software intended to provide therapy for ADHD or any of its individual symptoms as an adjunct to clinician supervised treatment.
Explore obstetrics/gynecology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Dec 13, 2023 to Jun 13, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
PrismiraK243729 · QFTLumos Labs, Inc.510(k)Jun 13, 2025FDA decision date
EndeavorOTCK233496 · QFTAkili Interactive Labs, Inc.510(k)Jun 14, 2024FDA decision date
EndeavorRxK231337 · QFTAkili Interactive Labs, Inc.510(k)Dec 13, 2023FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗